Yahoo Finance 
Yahoo Finance Plus Insurers Say Cyberattack That Hit Merck Was Warlike Act, Not Covered
The company lost $1.4 billion in 2017’s NotPetya attack, which has been linked to Russia, but insurers are fighting in court to avoid paying.
The company lost $1.4 billion in 2017’s NotPetya attack, which has been linked to Russia, but insurers are fighting in court to avoid paying.
The last year has seen a large number of job layoffs in the technology sector. Major companies like Salesforce, ESPN, Microsoft, Google, and Meta Platforms have all announced cuts to staffing -- a move that has been largely attributed to the rapid growth of online tech during the covid-19 lockdown. Amazon is one of the biggest companies announcing waves of job cuts -- in January, the company let go of more than 2,300 employees in the payments, health care, human resources, robotics, and web services departments.
Based on the average brokerage recommendation (ABR), Medical Properties (MPW) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
The legendary investor indicates that more than 60% of Comerica and U.S. Bancorp deposits are uninsured.
The number of infections from the Candida Auris fungus, which can be deadly for people who are already sick, is small but rapidly growing.
Elon Musk on late Monday offered his opinion on what the Federal Reserve should do with its benchmark interest rate. The Fed's FOMC is meeting for two days this week.
In this uncertain market environment, the educated investor would do well to seek out some signal that can cut through the noise and indicate the sound stock purchase choices. Following the legendary investors, the traders who build multi-billion dollar fortunes on the stock market trading scene, is a popular strategy – and when two of those investing legends agree… well, there’s a stock that should definitely get a second look. George Soros and Steve Cohen have both built fortunes, for themselv
The last few weeks have been rocky, with the collapse of Silicon Valley Bank, and the crypto-heavy Silvergate and Signature banks, dominating the headlines. For a short time, it seemed that the contagion would spread to the global financial giants. Now, however, it appears that we’ve managed to avoid a true banking crisis – and Raymond James’ chief investment officer Larry Adam has pointed out several reasons why. For starters, Adam notes that Credit Suisse, despite its troubles, found a way out
Dividends are payments that some companies make to shareholders to reward them for investing in them. Dividends can provide regular, predictable income to investors who also preserve the chance of profiting from price appreciation. Dividends can qualify for advantageous capital … Continue reading → The post How Do I Avoid Paying Tax on Dividends? appeared first on SmartAsset Blog.
Airfare prices move up and down based on two major things -- passenger demand and the cost of actually flying the plane. Domestic air travel traffic for 2022 rose 10.9% compared to the prior year. The nation's air traffic in 2022 was at 79.6% of the full-year 2019 level.
The same dynamics that have left some banks reeling have handed taxpayers a windfall. The Fed will have to navigate them, David Beckworth writes.
As beleaguered First Republic Bank considers its options, analysts at Morgan Stanley say there is a "bull case" for the stock if regulators insure customer deposits until the banking crisis ends. First Republic, whose shares have lost much of their value since the banking crisis started in the U.S. on March 8, is among the banks that have been speaking to peers and investment firms about potential deals in the wake of U.S. regulators taking over Silicon Valley Bank and Signature Bank this month following bank runs. Morgan Stanley analyst Manan Gosalia set a target price of $54 for First Republic shares, which were down 4.4% at $15.08 on Wednesday afternoon in New York.
You're in a race against time and your dream retirement awaits at the finish line.
After Silicon Valley Bank collapsed the Fed is between a rock and a hard place over whether to raise interest rates to lower inflation or not.
UBS on Sunday agreed to buy rival Swiss bank Credit Suisse for 3 billion Swiss francs ($3.23 billion) in stock and agreed to assume up to 5 billion francs ($5.4 billion) in losses, in a shotgun merger engineered by Swiss authorities to avoid more market-shaking turmoil in global banking. Klein, a veteran dealmaker, was merging his eponymous advisory boutique into Credit Suisse's investment banking operations to create CS First Boston as a standalone business which he would have led from New York. UBS has now assigned a legal team to examine how to void the contract Credit Suisse signed with Klein in the cheapest way possible, according to the FT report, which cited people with direct knowledge of the matter.
(Bloomberg) -- Ford Motor Co.’s Jim Farley was told recently of a survey that found investors overwhelmingly believe legacy automakers can’t be cost competitive with Tesla Inc.Most Read from BloombergBomb Threat Called In to New York Court Where Trump Hearing HeldFed Caught Between Inflation and Bank CrisisA New Chapter of Capitalism Emerges From the Banking CrisisXi Aligns With Putin Against US, But Hesitates on Gas DealFirst Republic Rescue May Rely on US Backing to Reach a Deal“I’m with them,
Rivian shares continue to trade around the level of cash on the balance sheet, leaving investors to ask: What gives?
Small biotech company 89bio scored a win Wednesday in fatty liver disease, and ETNB stock rocketed well above its 50-day moving average.
Is the government doing more harm than good?
Selecta Biosciences Inc (NASDAQ: SELB) and Swedish Orphan Biovitrum AB (OTC: BIOVF) announced topline results from the Phase 3 DISSOLVE I & II trials of SEL-212 in adult patients with chronic refractory gout. Also Read: Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts. The DISSOLVE I (the U.S. Study) met its primary endpoint, with 56% of patients receiving monthly doses of SEL-212 at 0.15 mg/kg achieving a response (defined as achievement and maint